GlycoMimetics Inc【GLYC】株式ニュース | ADVFN

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
GlycoMimetics Inc (GLYC)
GlycoMimetics Inc (GLYC) ニュース

GlycoMimetics Inc (GLYC)

0.242

0.0255

(11.78%)

終了 12月25日 6:00AM

0.2382

-0.0038

(-1.57%)

取引時間後: 6:56AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 PR Newswire WALTHAM, Mass., Nov...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that data from multiple clinical trials studying uproleselan in patients with acute myeloid...

Form SC 13D - General Statement of Acquisition of Beneficial Ownership

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma

Following closing, the combined company will advance Crescent’s portfolio of precision-engineered biologics to improve outcomes for patients with...

GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint

GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Spending4fun

Spending4fun 1月前

Tomorrow November 19th, GLYC will be presenting thier developments at the London Healthcare conference. Hopefully this results into this stock shooting up. 🚀🚀

BurgerKing82

BurgerKing82 1月前

Looks interesting

BurgerKing82

BurgerKing82 1月前

Looks interesting

TechandBio

TechandBio 2月前

GLYC Sold at .60 yesterday for 203% profit.

Next micro cap buyout or hostile take over will be BFRI interesting price action after hours FDA approved drug for AK skin cancer with late stage pipeline for Basil Cell and Squamous cell carcinoma Phase 3 and Acne Phase 2 call your dermatologist I bet they use Ameluz
the FDA also just green lighted 3 tubes can be used in a single session from 1 $400 a tube =$1200

https://www.biofrontera-us.com/research/product-pipeline

https://www.investing.com/news/company-news/biofrontera-locks-phase-3-sbcc-study-database-for-analysis-93CH-3662035

https://us.ameluz.com/
$GLYC

INV4

Bought some more GLYC this morning.

================

Biotech Up Over +100% Premarket Following Merger And Funding Announcement

Tuesday, October 29, 2024

A Maryland-based biotech company is already dominating Tuesday’s session prior to the opening bell after it was announced that the company will be merging with Crescent Biopharma and that it secured approximately $200 million in funding to financing operations through 2027, according to this morning’s release.

Traders were quick to snatch up shares of GlycoMimetics Inc. (Nasdaq:GLYC), with the current bid sitting at $0.3694/share (+119.62% implied open for sellers) at the time of writing. It should be an exciting session for this micro cap!

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.

https://www.allpennystocks.com/specialreportsus/3692/biotech-up-over-100-premarket-following-merger-and-funding-announcement?utm_source=advfn

$GLYC

dennisv

dennisv 2月前

Renewed Opportunities!

hondaboost

hondaboost 2月前

My tons of GLYC shares at $0.17 now have Huge gains!!! Go, go, go!!!!!

dennisv

dennisv 2月前

dennisv

dennisv 2月前

There is a lot of room.
Let's do it!

tw0122

Up 200% 09:44 AM EDT, 10/29/2024 (MT Newswires) -- GlycoMimetics' (GLYC) shares climbed by more than 125% early Tuesday after saying it has agreed to be acquired by Crescent Biopharma, a privately held biotechnology company advancing a pipeline of oncology therapeutics.

glenn1919

glenn1919 2月前

glyc....................................https://stockcharts.com/h-sc/ui?s=glyc&p=W&b=5&g=0&id=p86431144783

Sierra20

Sierra20 6月前

Bankruptcy proceedings next. You been warned. Check out my latest post.

hondaboost

hondaboost 6月前

GLYC was $3.5 in Jan. Institutions and mutual funds holding 50 million shares at dollars, out of 64 million OS.

hondaboost

hondaboost 6月前

GLYC, Chief Medical Officer bought 310,000 shares at $0.26 at open market on June 21. He must know something.

https://www.otcmarkets.com/filing/html?id=17638385&guid=RXO-kWK48IECJth

Invest-in-America

Invest-in-America 6月前

GLYC: Article here ---
https://www.defenseworld.net/2024/06/25/glycomimetics-inc-nasdaqglyc-insider-edwin-rock-buys-190000-shares.html#google_vignette

TheFinalCD

TheFinalCD 6月前

you usually post the bottom charts before they go

tw0122

Hitting .43s looking good

Sierra20

Sierra20 6月前

Delisting letter coming. You have been warned.

glenn1919

glenn1919 6月前

GLYC............................https://stockcharts.com/h-sc/ui?s=GLYC&p=W&b=5&g=0&id=p86431144783

subslover

subslover 6月前

Nice insider buys here = https://www.otcmarkets.com/filing/html?id=17638385&guid=NwO-kFXCNX90B3h

Monksdream

Monksdream 8月前

spindog

spindog 8月前

Well? Good thing i held off on taking a position….

Monksdream

Monksdream 8月前

Gotta wait it out

spindog

spindog 8月前

Hopefully the FDA will give GLYC the the green light after reviewing phase 3 data in June

Monksdream

Monksdream 8月前

Monksdream

Monksdream 9月前

willlbone

willlbone 2年前

INFINITI

INFINITI 2年前

TechandBio

TechandBio 2年前

Picked up a few heavy racks of shares under 2.95 today.

$GLYC

Invest-in-America

Invest-in-America 2年前

GLYC: Hey!!!! WHAT???? (HA-HA!!)

makinezmoney

makinezmoney 2年前

$GLYC: The chart is screaming bullflag breakout on 100day chart

Now at 2.50

Perfect BULL FLAG.

NICE

GO $GLYC

TommyBoyTrader9460

TommyBoyTrader9460 2年前

$GLYC Crazy runner here..on watch to see if it continues as insider bought a ton of shares..

https://stocktwits.com/soll/message/497100283

https://stockcharts.com/c-sc/sc?s=GLYC&p=D&b=5&g=0&i=0&r=1668953354914

Invest-in-America

Invest-in-America 2年前

gail

yup and congrats on your other runner.

Invest-in-America

Invest-in-America 2年前

GO-GO-GO-GLYC!!!

PS: Hey, Girl, tap my latest POSTS behind @GRND --- what a SPECTACLE that one is!!!! (I grabbed their WARRANTS!!)

gail

looking good here.

gail

wow, new highs hitting right now!

gail

and back to 2 bucks. lets see what tomorrow brings.

gail

boing, and back up she goes.

gail

manipulation bringing it …

..

down but lets see what happens.

gail

here we go, breaking 2 bucks big time now.

gail

its time to break 2 bucks and really move like it did in the past.

1hot toddy

1hot toddy 2年前

WOW WOW WOW CHIEF MEDICAL OFFICIER BOUGHT 200,000 SHARES $$$

he went from 0 shares to 200000 in two days. 2- 100000 shares buys 2 days

now 4 employees have bought shares.

1hot toddy

1hot toddy 2年前

WOOOOOOOOOOOOOOOOOW 63000 SHARE BUY $$$$$$$$$$$$$$$$

employees are buying toooooooooo

1hot toddy

1hot toddy 2年前

3 HUGE INSIDE BUYS BY 3 PEOPLE. 19K, 20K AND 25K $$$$$$$$$$$$$$$$

1.06/1.29 UP UP AND AWAY

willlbone

willlbone 3年前

Back to 99 cents.

MfridgeV2

MfridgeV2 4年前

Agreed. Things looking up. Load up while no one else wants it. ;)

fishhunter

fishhunter 4年前

Now is but time. The gap has filled, weak hands are out, corporate path is correct.

mining101

mining101 4年前

Depends at what level - if back to 2s first it’s a big loss till then

stockguard

stockguard 4年前

The Investment Case For GlycoMimetics
https://seekingalpha.com/article/4389595-investment-case-for-glycomimetics

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約